Scale -


  • Revenue is 172 Rs Cr; Annual Growth is 43 %; 5 Year CAGR is 43 %; in Bottom Quartile
  • Ebitda is 47.77 Rs Cr; Annual Growth is 48 %; 5 Year CAGR is 48 %
  • PBT is 13.66 Rs Cr; Annual Growth is 58 %; 5 Year CAGR is 58 %
  • PAT is 29.09 Rs Cr; Annual Growth is 42 %; 5 Year CAGR is 42 %
  • Quarterly Revenue is 87.56 Rs Cr; Continuous Growth over 3 Quarters

Profitability -


  • PAT Margin is 16.91 %; in Top Quartile
  • Quarterly Ebitda Margin is 18 %; Continuous Decline over 3 Quarters

Return -


  • ROCE is 17.36 %; in Top Quartile; Annual Decline is -31 %; 5 Year CAGR is -31 %
  • ROA is 7.62 %; Annual Decline is -33 %; 5 Year CAGR is -33 %
  • ROE is 12.38 %; Annual Decline is -51 %; 5 Year CAGR is -51 %

Efficiency -


  • Operating cash flow is -79.44 Rs Cr; Annual Decline is -252 %; in Bottom Quartile
  • Inventory Turnover Ratio is 2.1; in Bottom Quartile

Solvancy -


  • Debt/Equity is 0.19; Annual Decline is -77 %; 5 Year CAGR is -77 %
  • Long term Debt is 6.09 Rs Cr; Annual Decline is -84 %; 5 Year CAGR is -84 %
  • Total Debt is 43.65 Rs Cr; Annual Decline is -34 %; 5 Year CAGR is -34 %

Quality -


  • Change in Inventories/Total Expenses is -34 %; Annual Decline is -1066 %; in Bottom Quartile
  • Other Expenses/Total Expenses is 10 %; in Bottom Quartile
  • Operating cashflow/ebitda is -166 %; Annual Decline is -139 %; in Bottom Quartile
  • Operating cashflow/PAT is -273 %; Annual Decline is -148 %; in Bottom Quartile
  • Exceptional Items/PBT is 0 %; in Top Quartile
  • Current Tax/PAT is 41 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Anlon Healthcare Reports Q2 Revenue of 605 Million Rupees Versus 522 Million YoY
Anlon Healthcare CMD outlines growth strategy in interview
ANLON HEALTHCARE Lower Circuit Streak: Day 2 Price and Data